Ian Ratcliffe

Biography

 Mr. Ratcliffe is currently the CEO of Stemgent, a leading company delivering tools and expertise in advance stem cell science. Prior to Stemgent, Mr. Ratcliffe was President of Upstate, a leading provider of cell signaling research products and services. He also previously served as Upstate’s COO, CFO and EVP of Sales and Marketing. In his final post as President, Mr. Ratcliffe was instrumental in facilitating the acquisition of Upstate by Serologicals Corp., and he served as President of the Upstate division. Ian received his M.B.A. from the Darden Graduate School of Business Administration at the University of Virginia where he was awarded a William Shermet Award and Faculty Award for Academic Excellence. Mr. Ratcliffe is Chairman of Enzymatics (Boston, MA), a manufacturer of molecular biology reagents, and a Non-Executive Director of Asterand (LSE: ATD), a global supplier of characterized human tissue and human tissue-based research services.

Research Interest

 Cell signaling research products and services, Molecular biology